FDA Clearance Tracker · P180028-S014
HeartStart FRx Defibrillator (861304)
Last checked: Nov 20, 2026Latest source record: Feb 21, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Feb 21, 2024
Approved
Time to decision
29 days
Received Jan 23, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P180028-S014
- Device name
- HeartStart FRx Defibrillator (861304)
- Applicant
- Philips Medical Systems
- Applicant location
- Bothell, WA
- Received
- Jan 23, 2024
- Decided
- Feb 21, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P180028
Device type
- Device class
- Class III
- Regulation
- 21 CFR 870.5310
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
approval for a battery manufacturing site located at Panasonic Energy Mexico, S.A. de C.V., Escobedo N.L., Mexico
Source documents
Other decisions for Philips Medical Systems
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Zenition 30510(k)
K254205 · Decided Aug 7, 2026 · 221 days after receipt
Device type: Interventional Fluoroscopic X-Ray System (OWB) · Radiology & Imaging
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.